Australian Clinical Labs Ltd (AU:ACL) has released an update.
Australian Clinical Labs Ltd has announced that SSGA Funds Management, Inc. and its related entities have ceased to be substantial holders as of 27th September 2024. The notification, part of a regulatory requirement, outlines changes in relevant interests and voting securities previously disclosed on 26th September. This marks a significant shift in the company’s shareholder structure, which could interest investors monitoring the company’s stock.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.
